A new analysis published this week demonstrates that confronting several diseases at once is a viable way to make the most of limited donor dollars and national health care budgets, and save more lives.
February 03, 2012
November 30, 2011
A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa.
October 17, 2011
A new global Atlas charts prospects for malaria elimination by offering the first full-color, detailed depiction of a disease now declining in many parts of the globe and provides a visual tool to help focus resources where they are needed most.
July 07, 2011
An analysis of heart disease and stroke statistics collected in 192 countries by the World Health Organization (WHO) shows that the relative burden of the two diseases varies widely from country to country and is closely linked to national income, according to researchers at UCSF.
March 14, 2011
UCSF Global Health Sciences and the UCSF Bixby Center Safe Motherhood Program welcome supermodel Christy Turlington Burns for the California premiere of No Woman, No Cry.
November 04, 2010
UCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
October 29, 2010
The Lancet launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.
October 11, 2010
The UCSF Global Health Group will host a Bay Area Global Health Summit to focus on innovative ways of using technologies to improve global health over the next decade.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
August 17, 2010
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.